Read A E, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto I K, Zeldis J B, Ascher N L, Roberts J, Wright T L
University of California, San Francisco.
Transplant Proc. 1991 Feb;23(1 Pt 2):1504-5.
HCV infection is commonly found in patients with chronic liver disease undergoing liver transplantation. However, the presence of antibody to HCV does not appear to be associated with the development of hepatitis posttransplant. No other risk factors were identified that appear to predispose patients to development of hepatitis in the posttransplant period, including amount of blood product exposure. The role of immunosuppression in the acquisition and expression of liver disease caused by HCV remains to be determined.
丙型肝炎病毒(HCV)感染常见于接受肝移植的慢性肝病患者中。然而,HCV抗体的存在似乎与移植后肝炎的发生并无关联。未发现其他似乎使患者在移植后易患肝炎的危险因素,包括血液制品暴露量。免疫抑制在由HCV引起的肝病的获得和表现中的作用仍有待确定。